United States · Biopharma startup

Elevation Oncology

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Email

Funding reportedLast round: Post ipo equity

BiopharmaNew York, United States

What company datasets say Elevation Oncology raised

Funding, as reported

Reported in all$198Min dollars
Rounds4
Last roundPost ipo equity
Last round dateJun 2023
Investors listed12

Founders and team

From the SEC filings it signed: 2 on the team.

  • Shawn LelandExecutive Officer, Director, Promoteri
  • Steven ElmsExecutive Officer, Director, Promoteri

On the board, as filediAndrew PhillipsColin WalshLori HuRichard GasterTimothy Clackson

On 2 portfolio pages

Investors who name them

Each firm lists Elevation Oncology on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biopharma in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Elevation Oncology in front of investors. Or tell us what we have wrong.

List your startupSend a correction